Quick Answer
Surgery Partners, Inc. reported Total Revenue of $132.26 million for fiscal year 2017.
Surgery Partners, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | -$77.90M +53.7% |
-$168.10M -1312.6% |
-$11.90M +78.2% |
-$54.60M +23.0% |
-$70.90M +38.9% |
-$116.10M -55.2% |
| Diluted EPS | -$0.61 +54.1% |
-$1.33 -1377.8% |
-$0.09 +84.7% |
-$0.59 +47.3% |
-$1.12 +64.9% |
-$3.19 -39.3% |
| Total Assets | $8.12B +2.9% |
$7.89B +14.7% |
$6.88B +2.9% |
$6.68B +9.2% |
$6.12B +13.0% |
$5.41B +7.9% |
| Cash and Equivalents | $239.90M -11.0% |
$269.50M +37.6% |
$195.90M -30.8% |
$282.90M -27.4% |
$389.90M +22.6% |
$317.90M +242.9% |
| Stockholders Equity | $1.71B -4.3% |
$1.79B -9.9% |
$1.99B -0.6% |
$2.00B +83.5% |
$1.09B +842.0% |
$115.60M -61.1% |
| Operating Income | $389.50M +11.7% |
$348.80M +6.3% |
$328.00M -5.0% |
$345.20M +14.2% |
$302.20M +65.1% |
$183.00M -22.4% |
| Shares Outstanding | 129.32M +1.7% |
127.11M +0.4% |
126.59M +0.5% |
125.96M +41.0% |
89.33M +77.0% |
50.46M +2.4% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | March 31, 2018 | $417.37M | +45.8% | +215.6% |
| Net Income | September 30, 2025 | -$22.70M | +28.4% | -808.0% |
| Diluted EPS | September 30, 2025 | -$0.18 | +28.0% | -800.0% |
| Total Assets | September 30, 2025 | $7.95B | +5.5% | -0.1% |
| Cash and Equivalents | September 30, 2025 | $203.40M | -8.3% | -18.7% |
| Stockholders Equity | September 30, 2025 | $1.73B | -8.8% | -1.1% |
| Operating Income | September 30, 2025 | $105.70M | +73.6% | -5.4% |
| Shares Outstanding | September 30, 2025 | 129.02M | +1.5% | +0.6% |
- Surgery Partners, Inc. reported Total Revenue of $132.26 million for fiscal year 2017.
- Surgery Partners, Inc. showed a decrease of -88.5% in Total Revenue compared to the prior fiscal year.
- Surgery Partners, Inc. reported Net Income of -$77.90 million for fiscal year 2025.
- Surgery Partners, Inc. showed an increase of +53.7% in Net Income compared to the prior fiscal year.
- Surgery Partners, Inc. reported Diluted EPS of $0.61 per share (loss) for fiscal year 2025.
- Surgery Partners, Inc. showed an increase of +54.1% in Diluted EPS compared to the prior fiscal year.
- Surgery Partners, Inc. reported Total Assets of $8.12 billion for fiscal year 2025.
- Surgery Partners, Inc. showed an increase of +2.9% in Total Assets compared to the prior fiscal year.
- Surgery Partners, Inc. reported Cash and Equivalents of $239.90 million for fiscal year 2025.
- Surgery Partners, Inc. showed a decrease of -11.0% in Cash and Equivalents compared to the prior fiscal year.
- Surgery Partners, Inc. reported Stockholders Equity of $1.71 billion for fiscal year 2025.
- Surgery Partners, Inc. showed a decrease of -4.3% in Stockholders Equity compared to the prior fiscal year.
- Surgery Partners, Inc. reported Operating Income of $389.50 million for fiscal year 2025.
- Surgery Partners, Inc. showed an increase of +11.7% in Operating Income compared to the prior fiscal year.
- Surgery Partners, Inc. reported Shares Outstanding of 129.32 million shares for fiscal year 2025.
- Surgery Partners, Inc. showed an increase of +1.7% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: